A detailed history of Dakota Wealth Management transactions in Amgen Inc stock. As of the latest transaction made, Dakota Wealth Management holds 45,553 shares of AMGN stock, worth $12 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
45,553
Previous 45,589 0.08%
Holding current value
$12 Million
Previous $14.2 Million 3.04%
% of portfolio
0.34%
Previous 0.34%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$309.38 - $337.38 $11,137 - $12,145
-36 Reduced 0.08%
45,553 $14.7 Million
Q2 2024

Jul 19, 2024

SELL
$262.75 - $319.31 $385,979 - $469,066
-1,469 Reduced 3.12%
45,589 $14.2 Million
Q1 2024

Apr 24, 2024

BUY
$268.87 - $324.56 $4.82 Million - $5.82 Million
17,918 Added 61.49%
47,058 $13.4 Million
Q4 2023

Jan 30, 2024

BUY
$255.7 - $288.46 $574,046 - $647,592
2,245 Added 8.35%
29,140 $8.39 Million
Q3 2023

Oct 23, 2023

BUY
$218.65 - $271.46 $515,795 - $640,374
2,359 Added 9.61%
26,895 $7.23 Million
Q2 2023

Jul 31, 2023

BUY
$214.27 - $253.37 $3.63 Million - $4.3 Million
16,963 Added 223.99%
24,536 $5.45 Million
Q1 2023

Apr 14, 2023

SELL
$225.79 - $275.2 $1.6 Million - $1.95 Million
-7,090 Reduced 48.35%
7,573 $1.83 Million
Q4 2022

Feb 07, 2023

BUY
$229.03 - $291.01 $1.45 Million - $1.84 Million
6,320 Added 75.75%
14,663 $3.85 Million
Q3 2022

Nov 10, 2022

BUY
$224.46 - $253.15 $1.15 Million - $1.3 Million
5,124 Added 159.18%
8,343 $1.88 Million
Q2 2022

Aug 05, 2022

BUY
$230.71 - $256.74 $150,422 - $167,394
652 Added 25.4%
3,219 $783,000
Q1 2022

May 13, 2022

BUY
$219.27 - $242.57 $562,866 - $622,677
2,567 New
2,567 $621,000
Q3 2021

Nov 15, 2021

SELL
$212.27 - $248.7 $430,695 - $504,612
-2,029 Closed
0 $0
Q2 2021

Aug 02, 2021

BUY
$233.58 - $259.14 $280,296 - $310,968
1,200 Added 144.75%
2,029 $495,000
Q1 2021

May 10, 2021

BUY
$221.91 - $258.6 $183,963 - $214,379
829 New
829 $206,000
Q4 2020

Feb 12, 2021

SELL
$216.38 - $257.67 $197,122 - $234,737
-911 Closed
0 $0
Q3 2020

Nov 04, 2020

SELL
$234.65 - $260.95 $1.39 Million - $1.54 Million
-5,907 Reduced 86.64%
911 $232,000
Q2 2020

Aug 07, 2020

BUY
$197.81 - $242.74 $955,224 - $1.17 Million
4,829 Added 242.79%
6,818 $1.61 Million
Q1 2020

Apr 29, 2020

BUY
$182.24 - $241.7 $362,475 - $480,741
1,989 New
1,989 $403,000
Q2 2019

Aug 07, 2019

SELL
$166.7 - $195.41 $297,892 - $349,197
-1,787 Closed
0 $0
Q1 2019

Apr 29, 2019

BUY
$180.87 - $203.88 $323,214 - $364,333
1,787 New
1,787 $339,000
Q1 2019

Apr 18, 2019

SELL
$180.87 - $203.88 $3.72 Million - $4.19 Million
-20,556 Closed
0 $0
Q4 2018

Jan 22, 2019

BUY
$178.4 - $208.25 $37,820 - $44,149
212 Added 1.04%
20,556 $4.24 Million
Q3 2018

Nov 07, 2018

BUY
$185.29 - $208.89 $793,226 - $894,258
4,281 Added 26.65%
20,344 $4.22 Million
Q2 2018

Aug 09, 2018

BUY
$166.05 - $186.51 $1.19 Million - $1.33 Million
7,139 Added 80.0%
16,063 $2.97 Million
Q1 2018

Apr 10, 2018

BUY
$169.43 - $198.0 $508 - $594
3 Added 0.03%
8,924 $1.52 Million
Q4 2017

Jan 16, 2018

SELL
$168.79 - $188.59 $25,318 - $28,288
-150 Reduced 1.65%
8,921 $1.55 Million
Q3 2017

Oct 16, 2017

BUY
$167.29 - $191.0 $1.52 Million - $1.73 Million
9,071
9,071 $1.69 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Dakota Wealth Management Portfolio

Follow Dakota Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dakota Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Dakota Wealth Management with notifications on news.